AB126713

重组Anti-IL-28A + IL-28B抗体[EPR5328(2)]

Anti-IL-28A + IL-28B antibody [EPR5328(2)]

RabMAb
Recombinant
了解详情

Be the first to review this product! Submit a review

(1 Publication)

Rabbit Recombinant Monoclonal IFNL2 antibody. Suitable for WB and reacts with Recombinant full length protein - Human samples. Cited in 1 publication.

查看别名

IL28A, ZCYTO20, IFNL2, Interferon lambda-2, IFN-lambda-2, Cytokine Zcyto20, Interleukin-28A, IL-28A

2 Images

Lab

Western blot - Anti-IL-28A + IL-28B antibody [EPR5328(2)] (AB126713)

Blocking buffer and concentration 5% NFDM/TBST
Diluting buffer and concentration 5% NFDM/TBST

All lanes:

Western blot - Anti-IL-28A + IL-28B antibody [EPR5328(2)] (ab126713) at 1/5000 dilution

All lanes:

Human IL-28A (amino acids 27-200) recombinant protein

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 19 kDa

false

Exposure time: 120s

Unknown

Western blot - Anti-IL-28A + IL-28B antibody [EPR5328(2)] (AB126713)

Exposure time

Lane 1 : 40 seconds

Lane 2 : 3 second

Buffer and concentration : 5% NFDM /TBST

All lanes:

Western blot - Anti-IL-28A + IL-28B antibody [EPR5328(2)] (ab126713) at 1/1000 dilution

Lane 1:

Human IL-28A recombinant protein (aa 27 to 200) at 0.01 µg

Lane 2:

House made His-tagged full length human IL-28B recombinant protein at 0.01 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

false

不同偶联物与剂型 (1)

Carrier free

Anti-IL-28A + IL-28B antibody [EPR5328(2)] - BSA and Azide free

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

EPR5328(2)

亚型

IgG

不含载体蛋白

应用

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

style

left-column

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Recombinant full length protein - Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" } } }

style

left-column

产品详情

Patented technology
Our RabMAb^® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb^® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production

For more information, read more on recombinant antibodies.

style

left-column

性能和储存信息

形式

Liquid

纯化工艺

Affinity purification Protein A

存储溶液

pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA

运输条件

Blue Ice

储存信息

Stable for 12 months at -20°C

style

left-column

style

left-column

style

left-column

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

Visit the General protocols
Visit the Troubleshooting

style

left-column

靶点信息

Cytokine with antiviral, antitumour and immunomodulatory activities. Plays a critical role in the antiviral host defense, predominantly in the epithelial tissues. Acts as a ligand for the heterodimeric class II cytokine receptor composed of IL10RB and IFNLR1, and receptor engagement leads to the activation of the JAK/STAT signaling pathway resulting in the expression of IFN-stimulated genes (ISG), which mediate the antiviral state. Has a restricted receptor distribution and therefore restricted targets : is primarily active in epithelial cells and this cell type-selective action is because of the epithelial cell-specific expression of its receptor IFNLR1. Seems not to be essential for early virus-activated host defense in vaginal infection, but plays an important role in Toll-like receptor (TLR)-induced antiviral defense. Plays a significant role in the antiviral immune defense in the intestinal epithelium. Exerts an immunomodulatory effect by up-regulating MHC class I antigen expression.

See full target information IFNL2

其他靶点

IFNL3

style

left-column

文献 (1)

Recent publications for all applications. Explore the full list and refine your search

Science advances 11:eady6386 PubMed40991712

2025

Site-specific adaptive nanovesicles for oral insulin delivery.

Applications

Unspecified application

Species

Unspecified reactive species

Bozhang Xia,Fengfei Xu,Junge Chen,Shaobo Shan,Jiuheng Shen,Yuxuan Zhang,Jinjin Wang,Ziran Zhou,Weilun Sun,Yaru Jia,Ya-Li Zhang,Jie Zhong,Gang Zhang,Yichen Wan,Zhongbo Hu,Wenlin An,Yubo Fan,Massimo Bottini,Jinqiang Wang,Xing-Jie Liang

View all publications

style

left-column

style

left-column

style

right-column

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂，为您科研的每一步提供支持。若我们的产品未能达到预期性能，我们向您提供 Abcam Product Promise 保障。

详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com

重组Anti-IL-28A + IL-28B抗体[EPR5328(2)]